Featured Research

from universities, journals, and other organizations

Early Vision Screening Associated With Better Eyesight In Children With Amblyopia

Date:
April 14, 2008
Source:
JAMA and Archives Journals
Summary:
Children who screen positive for amblyopia, reduced vision in one eye, before age 2 appear to have better visual outcomes than those whose vision problems are detected during screenings between ages 2 and 4.

Children who screen positive for amblyopia, reduced vision in one eye, before age 2 appear to have better visual outcomes than those whose vision problems are detected during screenings between ages 2 and 4, according to a new report.

Screening for amblyopia typically consists of visual acuity screening--where patients are asked to read letters on a chart--along with an examination to detect cataract, problems with eye alignment and other risk factors for the condition, according to background information in the article. Conventional visual acuity testing requires that children are old enough to cover one eye and read visual charts, whereas objective screening for risk factors and newer techniques involving taking photographs of the eye (photoscreening) can be performed in younger children.

Between 1996 and 2006, Alaska Blind Child Discovery--a cooperative, charitable research effort to offer vision screening to Alaskan children--used photoscreening to detect visual problems in 21,367 rural and urban Alaskan children through grade 2. Valerie G. Kirk and colleagues at Ophthalmic Associates, Anchorage, assessed the 94 children who screened positive before age 4 and were treated and followed for at least two years.

After amblyopia treatment, the 36 children who were screened before age 2 had better vision than the 58 who were screened between ages 2 and 4. "Despite similar levels of amblyogenic risk factors, the proportion of children failing to reach a visual acuity of 20/40 was significantly less among those screened before age 2 years (5 percent) than in those screened from ages older than 2 years and younger than 4 years (17 percent)," the authors write.

"Very early photoscreening yields better visual outcomes in amblyopia treatment compared with later photoscreening in preschool-aged children," they conclude.

Journal reference: Arch Ophthalmol. 2008;126[4]:489-492.


Story Source:

The above story is based on materials provided by JAMA and Archives Journals. Note: Materials may be edited for content and length.


Cite This Page:

JAMA and Archives Journals. "Early Vision Screening Associated With Better Eyesight In Children With Amblyopia." ScienceDaily. ScienceDaily, 14 April 2008. <www.sciencedaily.com/releases/2008/04/080414161502.htm>.
JAMA and Archives Journals. (2008, April 14). Early Vision Screening Associated With Better Eyesight In Children With Amblyopia. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2008/04/080414161502.htm
JAMA and Archives Journals. "Early Vision Screening Associated With Better Eyesight In Children With Amblyopia." ScienceDaily. www.sciencedaily.com/releases/2008/04/080414161502.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins